Tuesday, May 11, 2010

The 2010 TIME 100

No, we didn't actually write this blog entry, but we had to share it.... And Yes...we know its been over a week since Shiner and we still have not updated our blog...Will is working on that post and it will be here soon with photos, I promise.

And even though I couldn't be more proud of Will's 100 miles from Austin to Shiner (in 5 hours and 23 minutes...a teaser to his entry) this letter below ROCKS...and had to be posted!

This is YOUR money...the money you give to individuals like Will and I. So all of us together, really make a difference in helping fund (and find) a cure! GO TEAM!

LLS Funded Researcher is on Time Magazine's List of 100 Most Influential People

Dear Friend of LLS:

I am pleased to share exciting news about Larry Kwak, M.D., Ph.D., a researcher funded by The Leukemia & Lymphoma Society. Dr. Kwak was recently named one of TIME Magazine's "100 Most Influential People," for his role in advancing custom-made vaccines for patients with lymphoma.

Dr. Kwak, professor and chair of the Department of Lymphoma and Myeloma at The University of Texas M.D. Anderson Cancer Center in Houston, has focused his work on harnessing the power of the immune system of patients with follicular non-Hodgkin's lymphoma to fight their cancer. The vaccines are developed by taking proteins from the patient's own tumor, training them to find and kill lymphoma cells and then injecting them back into the patient. Currently in late stage clinical trials, the vaccines have been shown to extend disease-free survival for more than a year.

In 2007, LLS awarded Dr. Kwak a five-year, $6.25 million Specialized Center of Research grant, our most prestigious research award. These grants are distinctive in that they encourage at least three laboratories at the same or different institutions to work together. In addition to continuing his work on the personalized lymphoma vaccines, this grant is enabling Dr. Kwak to expand his research to develop immunotherapies for patients with leukemia and myeloma as well.

Throughout his distinguished career, Dr. Kwak has been on the cutting edge of researching and developing novel immunotherapies that are already showing a clear benefit for patients with cancer. We are proud of Dr. Kwak's well-deserved recognition and are honored to have played a role in helping to advance this life-saving work.

To read more about Dr. Kwak's inclusion in the "2010 Time 100" please visit
Time Magazine's website, and to learn more about our Research programs visit www.LLS.org. Please join us in taking pride in Dr. Kwak's achievements.

John E. Walter
President & CEO (LLS)

share on: FACEBOOK

1 comment:

  1. Ohhh! I'm posting this on my blog too! What a great idea!